Integra Lifesciences (IART) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist

19.230
-0.040-0.21%

Close Oct 11 16:00 ET

19.200
-0.030-0.16%

Post 20:02 ET

1.49BMarket Cap66.31P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | B of A Securities Maintains Underperform on Integra Lifesciences, Lowers Price Target to $18
BenzingaOct 7 13:12 ET
Integra LifeSciences Upgraded to Neutral From Sell at BTIG
TipRanksOct 7 06:38 ET · Ratings
BTIG Upgrades Integra Lifesciences(IART.US) to Hold Rating, Maintains Target Price $20
Moomoo NewsOct 7 06:31 ET · Ratings
Integra Lifesciences Sell Rating: Overly Ambitious Targets Amid Persistent Operational Challenges
TipRanksOct 7 06:15 ET · Ratings
Integra LifeSciences Holdings (NASDAQ:IART) Has A Somewhat Strained Balance Sheet
Simply Wall StOct 5 08:15 ET
Unveiling 10 Analyst Insights On Integra Lifesciences
BenzingaOct 1 14:02 ET

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.